ARTH Company News 10-Q: ARCH THERAPEUTICS, INC.
Post# of 5325
Posted On: 10/26/2013 2:04:00 PM
ARTH Company News
10-Q: ARCH THERAPEUTICS, INC. 6:35 p.m. Aug. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: ALMAH,INC 11:50 a.m. May 20, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: ALMAH,INC 1:42 p.m. Dec. 31, 2012 - Edgar Online - (EDG = 10Q, 10K)
Arch Therapeutics Co-Founder Dr. Ellis-Behnke to Speak at Nanomanufacturing Summit 2013 in Philadelphia, October 15, 2013 9:01 a.m. Oct. 10, 2013 - Marketwire
Arch Therapeutics Announces Approval of $1 Million Massachusetts Life Sciences Center Accelerator Loan 9:02 a.m. Oct. 7, 2013 - Marketwire
Arch Therapeutics Announces Participation at the 2013 Boulder Peptide Symposium in Colorado September 25-27 9:01 a.m. Sept. 20, 2013 - Marketwire
Arch Therapeutics Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th 9:01 a.m. Sept. 3, 2013 - Marketwire
Arch Therapeutics Announces Plans for Upcoming Activities 3:07 p.m. Aug. 6, 2013 - Marketwire
SOUL, XUII, PMCM and AFFY added to OTC Stock Watch List at GSR 9:06 a.m. July 30, 2013 - ACCESSWIRE
Arch Therapeutics Reports on Current Activities 9:03 a.m. July 30, 2013 - Marketwire
XUII, SOUL, PEII and AFFY added to OTC Stock Watch List at GSR 9:01 a.m. July 26, 2013 - ACCESSWIRE
Arch Therapeutics Co-Founder Dr. Ellis-Behnke Speaks at 6th Annual CLINAM Nanomedicine Summit in Basel, Switzerland 9:51 a.m. July 23, 2013 - Marketwire
Arch Therapeutics Co-Founder Rutledge Ellis-Behnke Delivers Keynote at Nanomaterials Technology Transfer Conference in Corfu, Greece 9:02 a.m. July 16, 2013 - Marketwire
ARTH, XUII, AAMRQ and SCRC added to OTC Active Stock Watch List at GSR 9:02 a.m. July 16, 2013 - ACCESSWIRE
BIZM, ARTH, AAMRQ and SGLB added to Active OTC Watch List at EPR 9:07 a.m. July 11, 2013 - ACCESSWIRE
BIZM, ARTH, AAMRQ and SGLB added to Active OTC Watch List at EPR 9:07 a.m. July 11, 2013 - ACCESSWIRE
Arch Therapeutics Appoints Senior Management Team Members 9:01 a.m. July 8, 2013 - Marketwire
Arch Therapeutics Introduces Experienced Directors and Executive Leadership 9:02 a.m. July 2, 2013 - Marketwire
Arch Therapeutics Effects Merger to Commence Operations as a Life Science Company 5:06 p.m. June 27, 2013 - Marketwire
10-Q: ARCH THERAPEUTICS, INC. 6:35 p.m. Aug. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: ALMAH,INC 11:50 a.m. May 20, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: ALMAH,INC 1:42 p.m. Dec. 31, 2012 - Edgar Online - (EDG = 10Q, 10K)
Arch Therapeutics Co-Founder Dr. Ellis-Behnke to Speak at Nanomanufacturing Summit 2013 in Philadelphia, October 15, 2013 9:01 a.m. Oct. 10, 2013 - Marketwire
Arch Therapeutics Announces Approval of $1 Million Massachusetts Life Sciences Center Accelerator Loan 9:02 a.m. Oct. 7, 2013 - Marketwire
Arch Therapeutics Announces Participation at the 2013 Boulder Peptide Symposium in Colorado September 25-27 9:01 a.m. Sept. 20, 2013 - Marketwire
Arch Therapeutics Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th 9:01 a.m. Sept. 3, 2013 - Marketwire
Arch Therapeutics Announces Plans for Upcoming Activities 3:07 p.m. Aug. 6, 2013 - Marketwire
SOUL, XUII, PMCM and AFFY added to OTC Stock Watch List at GSR 9:06 a.m. July 30, 2013 - ACCESSWIRE
Arch Therapeutics Reports on Current Activities 9:03 a.m. July 30, 2013 - Marketwire
XUII, SOUL, PEII and AFFY added to OTC Stock Watch List at GSR 9:01 a.m. July 26, 2013 - ACCESSWIRE
Arch Therapeutics Co-Founder Dr. Ellis-Behnke Speaks at 6th Annual CLINAM Nanomedicine Summit in Basel, Switzerland 9:51 a.m. July 23, 2013 - Marketwire
Arch Therapeutics Co-Founder Rutledge Ellis-Behnke Delivers Keynote at Nanomaterials Technology Transfer Conference in Corfu, Greece 9:02 a.m. July 16, 2013 - Marketwire
ARTH, XUII, AAMRQ and SCRC added to OTC Active Stock Watch List at GSR 9:02 a.m. July 16, 2013 - ACCESSWIRE
BIZM, ARTH, AAMRQ and SGLB added to Active OTC Watch List at EPR 9:07 a.m. July 11, 2013 - ACCESSWIRE
BIZM, ARTH, AAMRQ and SGLB added to Active OTC Watch List at EPR 9:07 a.m. July 11, 2013 - ACCESSWIRE
Arch Therapeutics Appoints Senior Management Team Members 9:01 a.m. July 8, 2013 - Marketwire
Arch Therapeutics Introduces Experienced Directors and Executive Leadership 9:02 a.m. July 2, 2013 - Marketwire
Arch Therapeutics Effects Merger to Commence Operations as a Life Science Company 5:06 p.m. June 27, 2013 - Marketwire
(0)
(0)Scroll down for more posts ▼